机构：[1]State Key Laboratory of Biotherapy, Cancer Center and Collaborative Innovation Center of Biotherapy, West China Hospital of Sichuan University, Chengdu, 610041, China四川大学华西医院[2]Chengdu Zenitar Biomedical Technology Co., Ltd., Chengdu, 610041, China[3]Department of Emergency Medicine, Institute of Disaster Medicine, Institute of Emergency Medicine, Disaster Medical Center, West China Hospital of Sichuan University, Chengdu, 610041, China四川大学华西医院[4]Laboratory of Neuro-System and Multimorbidity, West China Hospital of Sichuan University, Chengdu, 610041, China四川大学华西医院[5]Innovation Center of Nursing Research, Nursing Key Laboratory of Sichuan Province, West China Hospital of Sichuan University, Chengdu, 610041, China四川大学华西医院[6]School of Pharmacy/School of Modern Chinese Medicine Industry, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, China
This work was supported by the National Key R&D Program of China
(grant no. 2023YFF1204905), the National Natural Science Foundation
of China (T2221004 and 22507084), the 1.3.5 Project for disciplines of
excellence, West China Hospital, Sichuan University (ZYGD23020), the
China Postdoctoral Science Foundation (2024M752280) and Sichuan
Science and Technology Support Program (2025ZNSFSC0688 and
2025ZNSFSC1726).
语种：
外文
PubmedID：
中科院(CAS)分区：
出版当年[2025]版：
大类|2 区医学
小类|1 区药物化学
最新[2025]版：
大类|2 区医学
小类|1 区药物化学
第一作者：
第一作者机构：[1]State Key Laboratory of Biotherapy, Cancer Center and Collaborative Innovation Center of Biotherapy, West China Hospital of Sichuan University, Chengdu, 610041, China
共同第一作者：
通讯作者：
通讯机构：[1]State Key Laboratory of Biotherapy, Cancer Center and Collaborative Innovation Center of Biotherapy, West China Hospital of Sichuan University, Chengdu, 610041, China[2]Chengdu Zenitar Biomedical Technology Co., Ltd., Chengdu, 610041, China[*1]State Key Laboratory of Biotherapy, Cancer Center and Collaborative Innovation Center of Biotherapy, West China Hospital of Sichuan University, Chengdu, 610041, China
推荐引用方式(GB/T 7714)：
Zhang Chufeng,Chen Yulian,Tang Minghai,et al.Discovery of benzothiazole derivatives as novel orally receptor-interacting protein kinase 1 (RIPK1) inhibitors for inflammatory disease therapy[J].European Journal Of Medicinal Chemistry.2025,302(Pt 3):118380.doi:10.1016/j.ejmech.2025.118380.
APA：
Zhang Chufeng,Chen Yulian,Tang Minghai,Zhang Shunjie,Yan Wei...&Chen Lijuan.(2025).Discovery of benzothiazole derivatives as novel orally receptor-interacting protein kinase 1 (RIPK1) inhibitors for inflammatory disease therapy.European Journal Of Medicinal Chemistry,302,(Pt 3)
MLA：
Zhang Chufeng,et al."Discovery of benzothiazole derivatives as novel orally receptor-interacting protein kinase 1 (RIPK1) inhibitors for inflammatory disease therapy".European Journal Of Medicinal Chemistry 302..Pt 3(2025):118380
